Jeremy Grantham started to build up the position in Horizon Therapeutics Plc in Q4 2022 and continued to invest until Q2 2023. Since then they sold 313 Thousand shares. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -123 Thousand shares
Q4 2023
Avg closing price
$116.18
Price range
$115.93
-
$116.30
Sold 60.6% shares (-190 Thousand shares)
Q3 2023
Avg closing price
$107.45
Price range
$98.98
-
$115.74
Increased shares by 45.0% (+97.1 Thousand shares)
Q2 2023
Avg closing price
$105.50
Price range
$96.34
-
$112.38
Increased shares by 387.3% (+172 Thousand shares)
Q1 2023